Peng Shou-chun, Li Zhen-hua, Kang Jian, Hou Xian-ming, Yu Run-jiang
Institute of Respiratory Disease, First Affiliated Hospital, China Medical University, Shenyang 110001, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Apr;31(4):260-3.
To determine whether clinical and physiologic variables and bronchoalveolar lavage fluid (BALF) cell profiles affect the survival of patients with idiopathic pulmonary fibrosis (IPF).
There were 43 patients with clinically diagnosed IPF in the study. The Kaplan-Meier method and the Log-rank test were used to estimate the survival in the two groups and Cox proportional hazard regression was used to evaluate the Hazard Ratio in the IPF patients.
The IPF patients presented with restrictive ventilatory disorders [FVC%: (61 +/- 18)%, TLC%: (54 +/- 13)%] and gas exchange impairment [D(L)CO%: (48 +/- 14)%]. The mean follow-up time was 30.7 months, and the median survival of IPF patients was 28.5 months after diagnosis. FVC ( Wald = 6.71, P < 0.01), TLC ( Wald = 12.37, P < 0.01) , D(L)CO ( Wald = 22.78, P < 0.01), neutrophil ( Wald = 16.26, P < 0.01) and eosinophil ( Wald = 7.73, P < 0.01) percentages were prognostic variables in the univariate Cox proportional hazard regression, and only D(L)CO (HR = 0.93, Wald = 15.77, P < 0.01) and the neutrophil percentage (HR = 1.07, Wald = 6.83, P < 0.01) were prognostic variables for IPF patients in the multivariate Cox proportional hazard regression.
The IPF patients were predominantly old males and presented with restrictive ventilatory disorders and gas exchange impairment. Glucocorticoids and/or cytotoxic drugs could not improve the prognosis for the IPF patients. DLCO and BALF neutrophil percentage were prognostic variables, and DLCO was negatively correlated with the prognosis while the neutrophil percentage was positively correlated with the prognosis in the IPF patients.
确定临床和生理变量以及支气管肺泡灌洗(BALF)液细胞谱是否影响特发性肺纤维化(IPF)患者的生存率。
本研究纳入43例临床诊断为IPF的患者。采用Kaplan-Meier法和Log-rank检验评估两组患者的生存率,采用Cox比例风险回归评估IPF患者的风险比。
IPF患者表现为限制性通气障碍[用力肺活量(FVC)%:(61±18)%,肺总量(TLC)%:(54±13)%]和气体交换受损[一氧化碳弥散量(D(L)CO)%:(48±14)%]。平均随访时间为30.7个月,IPF患者诊断后的中位生存期为28.5个月。在单因素Cox比例风险回归中,FVC(Wald=6.71,P<0.01)、TLC(Wald=12.37,P<0.01)、D(L)CO(Wald=22.78,P<0.01)、中性粒细胞(Wald=16.26,P<0.01)和嗜酸性粒细胞(Wald=7.73,P<0.01)百分比是预后变量,而在多因素Cox比例风险回归中,只有D(L)CO(风险比[HR]=0.93,Wald=15.77,P<0.01)和中性粒细胞百分比(HR=1.07,Wald=6.83,P<0.01)是IPF患者的预后变量。
IPF患者以老年男性为主,表现为限制性通气障碍和气体交换受损。糖皮质激素和/或细胞毒性药物不能改善IPF患者的预后。D(L)CO和BALF中性粒细胞百分比是预后变量,在IPF患者中,D(L)CO与预后呈负相关,而中性粒细胞百分比与预后呈正相关。